Transcript Document

Change in average Birmingham Vasculitis
Activity Score (BVAS) with MMF treatment
End point
Baseline
24 wk
52 wk
Mean
BVAS
9.1
2.81.9*
2.84.3**
*p=0.0013, **p=0.0044 vs baseline
Joy S et al. Nephrol Dial Transplant 2005; 20:
2725-2732.
MMF may offer less toxic treatment for ANCA-smallvessel vasculitis [Rheumawire > News; Dec 20, 2005]